Evidence map›Paper›PMID 36625882›Full record

ArticleEuropean radiology2023

Automated lung cancer assessment on 18F-PET/CT using Retina U-Net and anatomical region segmentation.

T Weikert, P F Jaeger, S Yang, M Baumgartner, H C Breit, D J Winkel, G Sommer, B Stieltjes, W Thaiss, J Bremerich and 2 more

Abstract read
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. AutoPET Challenge on Fully Automated Lesion Segmentation in Oncologic PET/CT Imaging, Part 2: Domain Generalization.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

T WeikertDepartment of Radiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland. thomas.weikert@usb.ch.ORCID http://orcid.org/0000-0001-9274-053X
P F JaegerDivision of Medical Image Computing, German Cancer Research Center, Im Neuenheimer Feld 223, 69120, Heidelberg, Germany.
S YangDepartment of Radiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.
M BaumgartnerDivision of Medical Image Computing, German Cancer Research Center, Im Neuenheimer Feld 223, 69120, Heidelberg, Germany.
H C BreitDepartment of Radiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.
D J WinkelDepartment of Radiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.
G SommerInstitute of Radiology and Nuclear Medicine, Hirslanden Klinik St. Anna, St. Anna-Strasse 32, 6006, Lucerne, Switzerland.
B StieltjesDepartment of Radiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.
W ThaissDepartment of Nuclear Medicine, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
J BremerichDepartment of Radiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.
K H Maier-HeinDivision of Medical Image Computing, German Cancer Research Center, Im Neuenheimer Feld 223, 69120, Heidelberg, Germany.
A W SauterDepartment of Radiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.

Funding

ESR/EIBIR Research Seed Grant
6 · The paper itself

Abstract

objectivesTo develop and test a Retina U-Net algorithm for the detection of primary lung tumors and associated metastases of all stages on FDG-PET/CT.

methodsA data set consisting of 364 FDG-PET/CTs of patients with histologically confirmed lung cancer was used for algorithm development and internal testing. The data set comprised tumors of all stages. All lung tumors (T), lymphatic metastases (N), and distant metastases (M) were manually segmented as 3D volumes using whole-body PET/CT series. The data set was split into a training (n = 216), validation (n = 74), and internal test data set (n = 74). Detection performance for all lesion types at multiple classifier thresholds was evaluated and false-positive-findings-per-case (FP/c) calculated. Next, detected lesions were assigned to categories T, N, or M using an automated anatomical region segmentation. Furthermore, reasons for FPs were visually assessed and analyzed. Finally, performance was tested on 20 PET/CTs from another institution.

resultsSensitivity for T lesions was 86.2% (95% CI: 77.2-92.7) at a FP/c of 2.0 on the internal test set. The anatomical correlate to most FPs was the physiological activity of bone marrow (16.8%). TNM categorization based on the anatomical region approach was correct in 94.3% of lesions. Performance on the external test set confirmed the good performance of the algorithm (overall detection rate = 88.8% (95% CI: 82.5-93.5%) and FP/c = 2.7).

conclusionsRetina U-Nets are a valuable tool for tumor detection tasks on PET/CT and can form the backbone of reading assistance tools in this field. FPs have anatomical correlates that can lead the way to further algorithm improvements. The code is publicly available. KEY POINTS: • Detection of malignant lesions in PET/CT with Retina U-Net is feasible. • All false-positive findings had anatomical correlates, physiological bone marrow activity being the most prevalent. • Retina U-Nets can build the backbone for tools assisting imaging professionals in lung tumor staging.

Indexed as

Lung NeoplasmsPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18HumansPositron-Emission TomographyRadiopharmaceuticalsSensitivity and SpecificityFluorodeoxyglucose F18RadiopharmaceuticalsArtificial intelligenceDeep learningLung neoplasmNeoplasm stagingPET/CT

Identifiers

PMID36625882
PMCPMC10182147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.